Related Experiment Videos
[C-reactive protein potential risk factor for cardiovascular disease].
Per Tornvall1, John Pernow, Lars-Olof Hansson
1Kardiologiska kliniken, Karolinska sjukhuset, Stockholm. per.tornvall@ks.se
Lakartidningen
|October 9, 2003
Summary
C-reactive protein (CRP) indicates inflammation and is linked to future coronary heart disease (CHD). Elevated CRP levels, even low ones, may predict cardiovascular events in healthy individuals and those with existing CHD.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Medicine
Context:
- C-reactive protein (CRP) is an acute phase protein synthesized by the liver in response to interleukin-6.
- CRP levels elevate significantly during inflammatory conditions like bacterial infections.
- Advanced assays enable precise measurement of low plasma CRP concentrations.
Purpose:
- To explore the association between elevated C-reactive protein (CRP) levels and the risk of future coronary heart disease (CHD).
- To investigate the role of CRP in the atherosclerotic process.
- To highlight the clinical implications of measuring and potentially treating elevated CRP.
Summary:
- Prospective studies indicate that increased, even low, plasma CRP concentrations are associated with a higher risk of developing or experiencing coronary heart disease (CHD).
- In vitro research suggests C-reactive protein (CRP) actively participates in the development of atherosclerosis.
- These findings underscore the clinical significance of CRP as a biomarker and potential therapeutic target.
Impact:
- Elevated C-reactive protein (CRP) levels, previously recognized as an inflammation marker, are now understood as a predictor of future cardiovascular events.
- The active role of CRP in atherosclerosis supports its evaluation as a target for interventions aimed at reducing coronary heart disease (CHD) risk.
- This research encourages further clinical investigation into managing elevated CRP levels for cardiovascular health.